JP2005509445A5 - - Google Patents

Download PDF

Info

Publication number
JP2005509445A5
JP2005509445A5 JP2003545852A JP2003545852A JP2005509445A5 JP 2005509445 A5 JP2005509445 A5 JP 2005509445A5 JP 2003545852 A JP2003545852 A JP 2003545852A JP 2003545852 A JP2003545852 A JP 2003545852A JP 2005509445 A5 JP2005509445 A5 JP 2005509445A5
Authority
JP
Japan
Prior art keywords
subject
prostate cancer
methylation
kit
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003545852A
Other languages
English (en)
Japanese (ja)
Other versions
JP4381142B2 (ja
JP2005509445A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036784 external-priority patent/WO2003044232A1/en
Publication of JP2005509445A publication Critical patent/JP2005509445A/ja
Publication of JP2005509445A5 publication Critical patent/JP2005509445A5/ja
Application granted granted Critical
Publication of JP4381142B2 publication Critical patent/JP4381142B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003545852A 2001-11-16 2002-11-15 前立腺癌の検出法 Expired - Lifetime JP4381142B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33329601P 2001-11-16 2001-11-16
PCT/US2002/036784 WO2003044232A1 (en) 2001-11-16 2002-11-15 Method of detection of prostate cancer

Publications (3)

Publication Number Publication Date
JP2005509445A JP2005509445A (ja) 2005-04-14
JP2005509445A5 true JP2005509445A5 (enExample) 2006-01-05
JP4381142B2 JP4381142B2 (ja) 2009-12-09

Family

ID=23302188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003545852A Expired - Lifetime JP4381142B2 (ja) 2001-11-16 2002-11-15 前立腺癌の検出法

Country Status (9)

Country Link
US (3) US7252935B2 (enExample)
EP (1) EP1456413B1 (enExample)
JP (1) JP4381142B2 (enExample)
AT (1) ATE393240T1 (enExample)
AU (1) AU2002352745A1 (enExample)
CA (1) CA2467455C (enExample)
DE (1) DE60226271T2 (enExample)
ES (1) ES2304462T3 (enExample)
WO (1) WO2003044232A1 (enExample)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090226915A1 (en) 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
US20090215024A1 (en) * 2001-01-24 2009-08-27 Health Discovery Corporation Biomarkers upregulated in prostate cancer
US20090215058A1 (en) * 2001-01-24 2009-08-27 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
US8008012B2 (en) * 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
US10533998B2 (en) 2008-07-18 2020-01-14 Bio-Rad Laboratories, Inc. Enzyme quantification
US7718364B2 (en) * 2003-03-25 2010-05-18 John Wayne Cancer Institute DNA markers for management of cancer
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US9394565B2 (en) 2003-09-05 2016-07-19 Agena Bioscience, Inc. Allele-specific sequence variation analysis
CN1898396A (zh) * 2003-10-20 2007-01-17 圣文森特医院(悉尼)有限公司 通过定量测定正常组织中的表观突变评价疾病的风险
ES2801379T3 (es) * 2003-12-01 2021-01-11 Epigenomics Ag Métodos y ácidos nucleicos para el análisis de la expresión génica asociada con el desarrollo de trastornos proliferativos de células de próstata
JP4537050B2 (ja) * 2003-12-25 2010-09-01 国立大学法人三重大学 前立腺癌、そのリスク又はその初期罹患の判定方法
WO2005089414A2 (en) * 2004-03-17 2005-09-29 The Johns Hopkins University Neoplasia diagnostic compositions and methods of use
US7608394B2 (en) * 2004-03-26 2009-10-27 Sequenom, Inc. Methods and compositions for phenotype identification based on nucleic acid methylation
AU2005230936B2 (en) 2004-03-26 2010-08-05 Agena Bioscience, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
WO2005111232A2 (en) * 2004-05-17 2005-11-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Silencing of tumor-suppressive genes by cpg-methylation in prostate cancer
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
US7632634B2 (en) * 2005-04-15 2009-12-15 University Of Maryland Biotechnology Institute Method and assay for early diagnosis of prostate cancer
US8268549B2 (en) * 2005-04-15 2012-09-18 University Of Maryland, Baltimore Method and assay for determining methylation of GAL3 promoter for early diagnosis of prostate cancer
US7851154B2 (en) * 2005-07-22 2010-12-14 Simon Daniel Spivack GC tag-modified bisulfite genomic DNA sequencing for continuous methylation spectra
US20070059753A1 (en) * 2005-09-15 2007-03-15 Tatiana Vener Detecting gene methylation
EP1951911A2 (en) 2005-11-08 2008-08-06 Euclid Diagnostics LLC Materials and methods for assaying for methylation of cpg islands associated with genes in the evaluation of cancer
US7906288B2 (en) * 2006-01-04 2011-03-15 The Johns Hopkins University Compare-MS: method rapid, sensitive and accurate detection of DNA methylation
EP3913375A1 (en) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2021113A2 (en) 2006-05-11 2009-02-11 Raindance Technologies, Inc. Microfluidic devices
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
IL186935A0 (en) * 2006-10-31 2008-02-09 Veridex Llc Prostate cancer field effect analysis methods and kits
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008101170A1 (en) * 2007-02-15 2008-08-21 Veridex, Llc Methods of detecting methylation patterns within a cpg island
JP2008202978A (ja) * 2007-02-16 2008-09-04 Hirosaki Univ 前立腺癌の診断方法
US20080254455A1 (en) * 2007-04-12 2008-10-16 Haiying Wang Detecting prostate cancer
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2245192A4 (en) * 2008-01-22 2011-04-13 Veridex Llc DETECTION OF GSTP1 HYPERMETHYLATION IN PROSTATE CANCER
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
CA2751688A1 (en) * 2009-02-06 2010-08-12 Biao He Emx2 in cancer diagnosis and prognosis
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
EP4484577A3 (en) 2010-02-12 2025-03-26 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP2622103B2 (en) 2010-09-30 2022-11-16 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
WO2012106525A2 (en) * 2011-02-02 2012-08-09 Exact Sciences Corporation Digital sequence analysis of dna methylation
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
US20140274767A1 (en) 2013-01-23 2014-09-18 The Johns Hopkins University Dna methylation markers for metastatic prostate cancer
US20140274757A1 (en) 2013-03-14 2014-09-18 Marie K. Kirby Differential Methylation Level of CpG Loci That Are Determinative of a Biochemical Reoccurrence of Prostate Cancer
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
US11427874B1 (en) 2019-08-26 2022-08-30 Epi One Inc. Methods and systems for detection of prostate cancer by DNA methylation analysis
CN110951871B (zh) * 2019-11-21 2024-01-05 瑞博奥(广州)生物科技股份有限公司 Pca3和psa rna检测试剂盒和扩增体系
CN116179694B (zh) * 2022-11-02 2024-11-05 武汉艾米森生命科技有限公司 检测甲基化水平的试剂在制备前列腺癌诊断产品中的应用以及前列腺癌诊断试剂盒
CN119391860B (zh) * 2024-12-25 2025-03-21 慧算基因科技(上海)有限公司 一种用于胰腺癌术后mrd检测及动态监测的引物探针组合物、试剂盒及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017704A (en) * 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
AUPP312998A0 (en) * 1998-04-23 1998-05-14 Commonwealth Scientific And Industrial Research Organisation Diagnostic assay
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US20040033490A1 (en) * 2000-03-31 2004-02-19 Laird Peter W. Epigenetic sequences for esophageal adenocarcinoma
US20050021240A1 (en) * 2000-11-02 2005-01-27 Epigenomics Ag Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA
DE10112515B4 (de) * 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität

Similar Documents

Publication Publication Date Title
JP2005509445A5 (enExample)
US9359646B2 (en) Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US20050084851A1 (en) Method
US20080254455A1 (en) Detecting prostate cancer
EP1818414A3 (de) Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
EP1440311A4 (en) AFFINITY SHIFTING probes for quantifying ANALYTE POLYNUCLEOTIDES
EP2816121A2 (en) Method for obtaining information on hepatocellular carcinoma and marker and kit for obtaining information on hepatocellular carcinoma
Crocitto et al. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results
WO2005023091A3 (en) Method for non-invasive prenatal diagnosis
WO2001075166A3 (en) Compositions and methods for detecting and quantifying gene expression
WO2005047543A3 (en) Ligation assay
Kashefi-Kheyrabadi et al. Ultrasensitive and amplification-free detection of SARS-CoV-2 RNA using an electrochemical biosensor powered by CRISPR/Cas13a
DK1436420T3 (da) Teststripassaysystem og fremgangsmåde til detektering af specifikke nucleinsyresekvenser
JP2008206511A (ja) 前立腺癌の特徴付け
CN111197087B (zh) 甲状腺癌鉴别标志物
EP1930446A2 (en) Method for obtaining information regarding quantity of DNA after non-methylated cytosine converting treatment in analysis of DNA methylation
HUP0204549A2 (hu) Eljárás adenovírus kimutatására és mennyiségi meghatározására
JP2007075114A (ja) 遺伝子メチル化の検出
EP1829964A4 (en) METHOD OF STUDYING A SEQUENCE OF A GENE
CA2687171A1 (en) Amplification method of methylated or unmethylated nucleic acid
WO2003072721A3 (en) Detection by sliding template amplification
CN114667355A (zh) 检测结直肠癌的方法
Lee et al. Washing-free electrochemical strategy to detect target DNA utilizing peroxidase mimicking DNAzyme
CA2172142A1 (en) Primers and probes for the amplification and detection of cmv nucleic acid
Doi et al. Application of fragment analysis based on methylation status mobility difference to identify vaginal secretions